NYSE:CLVT - Clarivate Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $19.14
  • Forecasted Upside: 42.54 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$13.43
▲ +0.05 (0.37%)

This chart shows the closing price for CLVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Clarivate Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLVT

Analyst Price Target is $19.14
▲ +42.54% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Clarivate in the last 3 months. The average price target is $19.14, with a high forecast of $28.00 and a low forecast of $16.00. The average price target represents a 42.54% upside from the last price of $13.43.

This chart shows the closing price for CLVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Clarivate.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/17/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/18/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/14/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/12/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/13/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/12/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/11/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/10/2022Morgan StanleyLower Price TargetOverweight$17.00 ➝ $16.00Low
7/12/2022Wells Fargo & CompanyInitiated CoverageOverweight$20.00Low
7/1/2022Royal Bank of CanadaLower Price TargetOutperform$23.00 ➝ $18.00Low
5/26/2022Morgan StanleyLower Price TargetOverweight$18.00 ➝ $17.00Low
4/19/2022The Goldman Sachs GroupLower Price TargetBuy$23.00 ➝ $20.00High
3/11/2022Morgan StanleyLower Price TargetOverweight$20.00 ➝ $19.00Medium
2/7/2022Morgan StanleyLower Price TargetOverweight$28.00 ➝ $20.00Medium
2/4/2022CitigroupDowngradeBuy ➝ Neutral$35.00 ➝ $16.00Low
2/3/2022BarclaysDowngradeOverweight ➝ Equal Weight$25.00 ➝ $16.00Low
1/18/2022BarclaysLower Price Target$30.00 ➝ $25.00High
12/21/2021CitigroupInitiated CoverageBuy$35.00Medium
12/13/2021The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$29.00High
12/2/2021Morgan StanleyBoost Price TargetOverweight$27.00 ➝ $28.00High
9/30/2021Morgan StanleyLower Price TargetOverweight$30.00 ➝ $28.00Low
8/16/2021Bank of AmericaInitiated CoverageBuy$28.00High
7/30/2021Morgan StanleyLower Price TargetOverweight$32.00 ➝ $30.00Low
5/18/2021Morgan StanleyBoost Price TargetOverweight$30.00 ➝ $32.00Medium
4/30/2021Morgan StanleyBoost Price TargetOverweight$28.00 ➝ $30.00High
4/30/2021B. RileyBoost Price TargetBuy$30.00 ➝ $33.00High
3/31/2021Jefferies Financial GroupInitiated CoverageBuy$30.00High
3/15/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$28.00High
3/11/2021CitigroupInitiated CoverageBuy$36.00Low
3/8/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$28.00Medium
3/4/2021Morgan StanleyLower Price TargetEqual Weight ➝ Overweight$30.00 ➝ $28.00N/A
2/26/2021Morgan StanleyLower Price TargetEqual Weight$30.00 ➝ $28.00High
(Data available from 8/11/2017 forward)

News Sentiment Rating

0.60 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/12/2022
  • 10 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/11/2022
  • 6 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
3/13/2022
  • 4 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
4/12/2022
  • 5 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
5/12/2022
  • 3 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
6/11/2022
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/11/2022
  • 7 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/10/2022

Current Sentiment

  • 7 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Clarivate logo
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $13.43
Low: $13.36
High: $13.58

50 Day Range

MA: $14.03
Low: $12.80
High: $15.03

52 Week Range

Now: $13.43
Low: $11.71
High: $26.73

Volume

24,407 shs

Average Volume

4,232,958 shs

Market Capitalization

$9.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Frequently Asked Questions

What sell-side analysts currently cover shares of Clarivate?

The following Wall Street sell-side analysts have issued reports on Clarivate in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Morgan Stanley, Royal Bank of Canada, The Goldman Sachs Group, Inc., TheStreet, and Wells Fargo & Company.
View the latest analyst ratings for CLVT.

What is the current price target for Clarivate?

7 Wall Street analysts have set twelve-month price targets for Clarivate in the last year. Their average twelve-month price target is $19.14, suggesting a possible upside of 43.1%. Bank of America Co. has the highest price target set, predicting CLVT will reach $28.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $16.00 for Clarivate in the next year.
View the latest price targets for CLVT.

What is the current consensus analyst rating for Clarivate?

Clarivate currently has 2 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CLVT will outperform the market and that investors should add to their positions of Clarivate.
View the latest ratings for CLVT.

What other companies compete with Clarivate?

Other companies that are similar to Clarivate include Bilibili, Zendesk, Zynga, Globant and Toast. Learn More about companies similar to Clarivate.

How do I contact Clarivate's investor relations team?

Clarivate's physical mailing address is 160 Blackfriars Road, London X0, SE1 8EZ. The company's listed phone number is 442074334000 and its investor relations email address is [email protected] The official website for Clarivate is www.clarivate.com. Learn More about contacing Clarivate investor relations.